Zhejiang Chengyi Pharmaceutical Co. Ltd. Class ASSE: 603811

Report for Q3 2024

Oct 29, 2024 · Issued by Zhejiang Chengyi Pharmaceutical Co. Ltd. Class A via Shanghai Stock Exchange

Report for Q3 2024

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment